Font Size: a A A

Research On The Illegal Disclosing Of The Accounting Information Of Er-kang Pharmaceutical Co.

Posted on:2020-12-20Degree:MasterType:Thesis
Country:ChinaCandidate:X L JiaFull Text:PDF
GTID:2439330596985041Subject:Accounting
Abstract/Summary:PDF Full Text Request
Accounting information as an important basis for external stakeholders to understand the company's actual operating conditions and profitability level,plays a vital role in its decision-making.Illegal disclosure of listed companies will not only endanger their own development,reduce economic and social benefits,increase operational risks,but also disrupt the order of capital market,even induce social credit crisis,affecting the healthy and long-term development of socialist market economy.Therefore,it is of great practical significance to study the illegal disclosure of accounting information of listed companies.With more and more enterprises responding to the call of the "one belt and one road",while actively expanding foreign trade and strengthening overseas cooperation and exchanges,China's regulatory flaws in the information disclosure of overseas trade are gradually exposed.At the same time,in recent years,the disclosure of accounting information in the pharmaceutical industry has also attracted social attention.These problems are highlighted in Er-kang Pharmaceutical.Er-kang Pharmaceutical Accounting Information Disclosure has a huge impact and serious consequences.Therefore,on the basis of reviewing domestic and foreign information disclosure research literature,relevant theories,new policy trends and fully understanding of tracking Er-kang Pharmaceutical Case,this paper studies Er-kang Pharmaceutical Accounting Information Disclosure.This paper expounds the background of Er-kang Pharmaceutical Illegal Disclosure,reviews the cases of Er-kang Pharmaceutical Accounting Information Disclosure as a whole,and then studies the items,consequences and motivations of Er-kang Pharmaceutical Accounting Information Illegal Disclosure,and puts forward corresponding governance suggestions.This paper considers that the illegal disclosure of Er-kang Pharmaceutical Accounting Information has not only internal motivation such as profit-driven,imperfect governance structure,invalid internal control,market share grabbing,but also external motivation such as external audit not diligent and due diligence,weak supervision of regulatory authorities,lack of social responsibility of media,far less illegal cost than its available benefits.Accordingly,the paper puts forward suggestions on internal and external corporate governance.Internal governance suggestions include paying attention to the moral culture construction of managers,establishing an effective corporate governance structure,optimizing the ownershipstructure of listed companies,strengthening enterprise risk management,promoting internal communication and cooperation,optimizing internal audit and vigorously enhancing the comprehensive competitive advantage within the company.The suggestions of external governance include strengthening the independence of external audit,constructing a perfect supervision system of certified public accountants,improving the professional quality of certified public accountants,doing a good job in the selection of supervisors and the construction of overseas supervision system,and reasonably distributing the supervision power.Strengthen the awareness of media information responsibility ownership and improve and strengthen the laws and regulations of punishment for violations of the law.
Keywords/Search Tags:Er-kang Pharmaceutical, Accounting Information, Illegal Disclosure, Supervision System
PDF Full Text Request
Related items